Posted in M&A / Deals BioAegis and Prenosis partner for inflammatory disease therapies April 22, 2026 Pharmaceutical Technology BioAegis Therapeutics has entered a strategic partnership with Prenosis to advance AI-driven precision medicine for inflammatory diseases. M&A / DealsImmunology & InflammationRead full story